Growth and Investment Opportunities in IVF in APAC and Middle East

This technical report discusses the growth and consolidation of in vitro fertilization (IVF) in the Asia-Pacific (APAC) and Middle East regions. It outlines five key factors contributing to the increasing demand for IVF services, including rising cycle volumes, enhanced regulatory frameworks, market consolidation, the potential for medical tourism, and the importance of innovation in operational practices. The report notes that IVF cycle volume in these regions reached 1.5 million in 2021, with a projected compound annual growth rate (CAGR) of 8% over five years. It highlights the role of private equity investors and domestic providers in capitalizing on these growth opportunities. Additionally, the report emphasizes the significance of demographic trends, such as rising infertility rates and delayed childbearing, as well as the impact of regulatory environments on market dynamics. The findings suggest that the APAC and Middle East regions present a compelling investment landscape for various stakeholders in the IVF sector.